Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study [0.03%]
抗心律失常药物用于房颤的药理复律及性别差异：CANT II研究的新启示
Maciej T Wybraniec,Aleksander Maciąg,Dawid Miśkowiec et al.
Maciej T Wybraniec et al.
Background: Data on sex differences in terms of action of antiarrhythmic agents (AADs) are limited. This study aimed to evaluate the clinical profile of patients with atrial fibrillation (AF), and efficacy and safety of A...
Identifying associations between the social network index, its components, and the prevalence of cardiovascular diseases in Polish adults. Results of the cross-sectional WOBASZ II study [0.03%]
波兰成人社交网络指数、其组成与心血管疾病患病率相关性横断面调查WOBASZ II研究结果
Aleksandra M Piwońska,Jerzy Piwoński,Alicja Cicha-Mikołajczyk et al.
Aleksandra M Piwońska et al.
Background: Psychosocial risk factors are important determinants of cardiovascular diseases (CVDs): people involved in positive relationships live longer than those with low social support (SS). ...
Computed tomographic characteristics of congenital coronary artery fistulas in an adult population [0.03%]
成人先天性冠状动脉瘘的CT特征分析
Anna Maria Michałowska,Jarosław Skowroński,Ilona Michałowska et al.
Anna Maria Michałowska et al.
Background: Coronary artery fistulas (CAFs) are usually congenital coronary artery anomalies of termination. Aims: This study aimed to ...
Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners [0.03%]
家族性高胆固醇血症及其表现：基层医生实用指南
Panagiotis Anagnostis,Christina Antza,Matilda Florentin et al.
Panagiotis Anagnostis et al.
Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism, affecting almost 1 in 250 individuals worldwide. It is usually inherited via the autosomal dominant way and is characterized by aberrantly high tota...
Tomasz Stompór,Agata Winiarska
Tomasz Stompór
Chronic kidney disease (CKD) and heart failure (HF) represent two modern diseases of civilization and are closely related. According to the concept of cardio-renal and reno-cardiac syndromes, most patients with CKD are affected by cardiovas...
Preliminary results from the Polish multicenter registry on Impella in high-risk PCI and cardiogenic shock: Lessons learned and how to further improve outcomes [0.03%]
来自波兰多中心登记报告的初期结果：高危PCI和心脏源性休克患者的Impella治疗经验及进一步改善预后的措施
Mario Iannaccone,Marco Gamardella,Alaide Chieffo
Mario Iannaccone
Multicenter Study
Kardiologia polska. 2023;81(11):1069-1070. DOI:10.33963/v.kp.97978 2023
Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL) [0.03%]
波兰Impella辅助高危经皮冠状动脉介入治疗和心源性休克多中心登记处（IMPELLA-PL）
Arkadiusz Pietrasik,Aleksandra Gąsecka,Tomasz Pawłowski et al.
Arkadiusz Pietrasik et al.
Background: Impella is a percutaneous mechanical circulatory support device for treatment of cardiogenic shock (CS) and high-risk percutaneous coronary interventions (HR-PCIs). IMPELLA-PL is a national retrospective regis...
Multicenter Study
Kardiologia polska. 2023;81(11):1103-1112. DOI:10.33963/v.kp.97218 2023
Discontinuation of cardiac implantable electronic device therapy after transvenous lead extraction [0.03%]
经静脉导线拔除后的心脏植入式电子设备治疗中断
Andrzej Kutarski,Wojciech Jacheć,Jarosław Kosior et al.
Andrzej Kutarski et al.
Background: Patients with cardiac implantable electronic devices (CIEDs) may no longer be eligible for continued therapy. Aims: The stu...
Clinical features, etiology, and survival in patients with restrictive cardiomyopathy: A single-center experience [0.03%]
限制型心肌病患者的临床特征、病因及生存率：单中心报告
Justyna A Szczygieł,Piotr Michałek,Grażyna Truszkowska et al.
Justyna A Szczygieł et al.
Background: Numerous prognostic factors have been proposed for cardiac amyloidosis (CA). The knowledge about other subtypes of restrictive cardiomyopathy (RCM) is scant. ...
Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure [0.03%]
植入型心律转复除颤器治疗非缺血性收缩性心力衰竭患者室性心动过速/心室纤颤的预测因素分析
Ewa Jędrzejczyk-Patej,Michał Mazurek,Monika Lazar et al.
Ewa Jędrzejczyk-Patej et al.
Background: The benefit derived from implantable cardioverter-defibrillators (ICD) in subjects with non-ischemic systolic HF (NICM) is less well-established. ...